Köyceğiz Vocational School of Health Services, Health Care Services Department, Muğla Sıtkı Koçman University, Muğla, Turkey.
Faculty of Health Sciences, Physical Therapy and Rehabilitation Department, Ege University, İzmir, Turkey.
Neurol Sci. 2022 Sep;43(9):5471-5477. doi: 10.1007/s10072-022-06196-4. Epub 2022 Jun 9.
Examining sleep-related behavioral disorder strategies in detail for MS patients provides an essential assessment to address specific disease findings. The aim of the study was to demonstrate the reliability and validity of the Turkish Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis (MS).
A total of 100 MS patients were filled Sleep-Related Behaviors Questionnaire (SRBQ), Beck Depression Inventory (BDI), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). One week later, 30 randomly selected patients were refilled the SRBQ. The test-retest reliability, internal consistency, and contruct validity were determined.
The mean age of the individuals included in the study was 38.9 ± 11.0 years. The ICC value of the reproducibility of SRBQ was calculated as 0.877 (CI: 0.74-0.94). The test-retest reliability of the SRBQ was excellent (ICC > 0.80). Cronbach's alpha value of the SRBQ was 0.877, which indicates excellent consistency. The SRBQ had correlation coefficients of 0.573, 0.509, and 0.523 with ISI, PSQI, and BDI, respectively. The SRBQ had high validity (r > 0.50, p < 0.01).
The Turkish SRBQ was found to be valid and reliable in patients with MS. Owing to the long but comprehensive nature of the SRBQ, a low-cost detailed measurement could be obtained in clinical practice.
详细检查多发性硬化症 (MS) 患者的睡眠相关行为障碍策略，可提供针对特定疾病发现的重要评估。本研究旨在证明土耳其语睡眠相关行为问卷 (SRBQ) 在多发性硬化症患者中的可靠性和有效性。
共纳入 100 名 MS 患者填写睡眠相关行为问卷 (SRBQ)、贝克抑郁量表 (BDI)、失眠严重程度指数 (ISI) 和匹兹堡睡眠质量指数 (PSQI)。一周后，随机选择 30 名患者再次填写 SRBQ。确定了测试-重测信度、内部一致性和结构效度。
研究对象的平均年龄为 38.9±11.0 岁。SRBQ 可重复性的 ICC 值计算为 0.877（CI：0.74-0.94）。SRBQ 的测试-重测信度为优（ICC>0.80）。SRBQ 的 Cronbach's alpha 值为 0.877，表明一致性很好。SRBQ 与 ISI、PSQI 和 BDI 的相关系数分别为 0.573、0.509 和 0.523。SRBQ 具有较高的有效性（r>0.50，p<0.01）。
土耳其语 SRBQ 在 MS 患者中具有有效性和可靠性。由于 SRBQ 冗长但全面，因此在临床实践中可以获得低成本的详细测量结果。
